As our use of new MS drugs progresses, real-world evidence starts becoming available that usefully complements trials-derived knowledge. Beyond informing us on how to best move from one drug to another one, it can also refine our understanding of the longer-term consequences of the treatment choices we pose today and help us best tailoring drug choices to individual patient needs. To discuss these key elements, we have here a panel of experts who will complement mechanistic and trial considerations with their own extensive experiences, in order to share useable and practical advices and tips.
Dermatology
Geaccrediteerd voor apothekers (N° 26013040006 - 1 punt)
Accreditatie aangevraagd
Oncology
Geaccrediteerd voor artsen (N° 26029205 - 1.5 punten)
Dermatology
Geaccrediteerd voor artsen (N° 26029948 - 1 punt)
Neurology ...
Geaccrediteerd voor apothekers (N° 26013040004 - 1 punt)
Geaccrediteerde lezing voor artsen (26029205 - 1,5 CP)
Dr. Hendrickx en dr. Snauwaert onderzoeken de complexe wisselwerking tussen geheugen, stress en slaap.
